From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “immune checkpoint blockade” 135

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy
2023 Cells article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access

Lara Rosaline Heij, Jan Bednarsch, Xiuxiang Tan, Mika Rosin, Simone Appinger, Konrad Reichel, +10 more

20

citations
Dual Immune Checkpoint Blockade Induces Analogous Alterations in the Dysfunctional CD8+ T-cell and Activated Treg Compartment
2023 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers Open access

Anne M. van der Leun, Joleen J.H. Traets, Joris L. Vos, Joris B.W. Elbers, Sanne Patiwael, Xiaohang Qiao, +5 more

45

citations
Frailty of older patients is not reflected in the melanoma tumor microenvironment and treatment response to immune checkpoint blockade therapy
2026 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

A. Özkan, Marieke E. Ijsselsteijn, Ziena Abdulrahman, Manon van der Ploeg, Ellen Kapiteijn, Marije Slingerland, +6 more

0

citations
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade
2023 Cancer Immunology Research article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent

Saba Tabasum, Dinesh Thapa, Anita Giobbie‐Hurder, Jason L. Weirather, Marco Campisi, Pieter J. Schol, +6 more

29

citations
Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
2022 Molecular Biomedicine article Medicine Photodynamic Therapy Research Studies Open access

Chih Kit Chung, Zili Gu, Timo Schomann, Xiaoxu Dong, Ruben V. Huis in ‘t Veld, Marcel G M Camps, +3 more

43

citations
IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer
2022 Cancer Cell article Medicine Cancer Immunotherapy and Biomarkers Open access

Olga S. Blomberg, Lorenzo Spagnuolo, Hannah Garner, Leonie Voorwerk, Olga I. Isaeva, Ewald van Dyk, +22 more

212

citations
Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade
2022 Science Immunology article Medicine Cancer Immunotherapy and Biomarkers

Fiamma Berner, David Bomze, Christa Lichtensteiger, Vincent P. Walter, Rebekka Niederer, Omar Hasan Ali, +28 more

42

citations
Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy
2025 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers Open access

Iris L. Mimpen, Thomas Battaglia, Catherine Toner-Bartelds, Laurien Joanna Zeverijn, Birgit S. Geurts, Karlijn Verkerk, +15 more

6

citations
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study
2024 Nature Communications article Medicine Endometrial and Cervical Cancer Treatments Open access

Anneke L. Eerkens, Koen Brummel, Annegé Vledder, Sterre T. Paijens, Marta Requesens, Dominik Loiero, +20 more

30

citations
Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies
2024 British Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

Joao Gorgulho, Christoph Roderburg, Fabian Beier, Carsten Bokemeyer, Tim H. Brümmendorf, Sven Heiko Loosen, +1 more

29

citations
Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
2023 Journal of Clinical Investigation article Medicine Cancer Immunotherapy and Biomarkers Open access

Cristina Valero, Mahdi Golkaram, Joris L. Vos, Bin Xu, Conall W. R. Fitzgerald, Mark Andrew Lee, +16 more

31

citations
Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade
2023 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access

Joao Gorgulho, Christoph Roderburg, Fabian Beier, Carsten Bokemeyer, Tim H. Brümmendorf, Tom Luedde, +1 more

18

citations
From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy
2026 European Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers

S C M A Wijnen, Petros Dimitriadis, Lodewyk F.A. Wessels, Christian U. Blank

4

citations
742MO Neoadjuvant immune checkpoint blockade in mismatch repair deficient endometrial cancer
2023 Annals of Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

Marco de Bruyn, Anje Eerkens, K. Brummel, Annegé Vledder, Sterre T. Paijens, Marta Requesens, +14 more

1

citations
733MO γδT cells are effectors of immune checkpoint blockade in mismatch repair-deficient colon cancers with antigen presentation defects
2022 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Joris van de Haar, N.L. de Vries, V. Veninga, Myriam Chalabi, M. Ijsselsteijn, M. van der Ploeg, +7 more

0

citations
Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors
2023 OncoImmunology article Medicine Cancer Immunotherapy and Biomarkers Open access

Olga S. Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I. Isaeva, Hannah Garner, Max D. Wellenstein, +10 more

38

citations
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma
2021 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Medical Imaging Techniques and Applications Open access

Joris L. Vos, Charlotte L. Zuur, Laura A. Smit, Jan Paul de Boer, Abrahim A. Al-Mamgani, Michiel W. M. van den Brekel, +2 more

42

citations
Adjuvant immune checkpoint blockade revisited
2023 The Lancet Oncology article Medicine Cancer Immunotherapy and Biomarkers

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse H Huisman, Anke Pisters-van Roy, Simone N. Koole, Lonneke Timmers, Christian U. Blank, +1 more

8

citations
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
2023 Nature Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

Leonie Voorwerk, Olga I. Isaeva, Hugo M. Horlings, Sara Balduzzi, Maksim Chelushkin, Noor A. M. Bakker, +22 more

43

citations
Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma
2023 Nature Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access

Itske Fraterman, Irene L. M. Reijers, Petros Dimitriadis, Annegien Broeks, Maria Gonzalez, Alexander Maxwell Menzies, +8 more

57

citations
1617P Leucine-rich 2 glycoprotein 1 (LRG1) as potential systemic biomarker for response to neoadjuvant immune checkpoint blockade in stage III melanoma
2025 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Shizhen Chen, C.C.E. De Schrijver, Huub H. van Rossum, Theodora C. Linders, M.W. Lucas, Esmée P. Hoefsmit, +12 more

0

citations
HLA-G: A New Immune Checkpoint in Cancer?
2020 International Journal of Molecular Sciences article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 8 patents

Daniëlle Krijgsman, Jessica P Roelands, Wouter Hendrickx, Davide Bedognetti, Peter J.K. Kuppen

85

citations
Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors
2023 Cancer Immunology Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent

Ruben V. Huis in ‘t Veld, Sen Ma, Rhonda C. Kines, Anneli Savinainen, Cadmus Collins Rich, FERRY A. OSSENDORP, +1 more

19

citations
Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer
2021 Journal of Translational Medicine article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent

Jinyu Meng, Jin Peng, Jie Feng, Jochen Maurer, Xiao Li, Yan Li, +11 more

63

citations
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 Science article Medicine Cancer Immunotherapy and Biomarkers Open access

Jaroslav Žák, Isaraphorn Pratumchai, Brett S. Marro, Kristi Marquardt, Reza Beheshti Zavareh, Luke L. Lairson, +8 more

191

citations